A symposium focused on advancing glycobiology research and supporting emerging scientists.
Official title: The Translational Glycomics Symposium
Funded at Versiti Wisconsin, INC. · NIH-10999694 · Data updated 2026-11-12
The 2024 Translational Glycomics Symposium is a friendly gathering for new researchers and trainees to learn about the study of sugars in our bodies, with talks from experts on topics like aging, inflammation, and cancer, and it encourages everyone to connect and share ideas, especially those from underrepresented backgrounds.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Wisconsin, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $11,286 |
| NIH project number | 1R13HL176037-01 |
| Project ID | NIH-10999694 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include early-stage researchers, trainees, and clinicians interested in glycobiology and its applications in health and disease.
✕Less likely to help
Patients who are not involved in research or do not have a background in glycobiology may not directly benefit from this symposium.
What this research studies
The 2024 Translational Glycomics Symposium, organized by the Translational Glycomics Center at Versiti Blood Research Institute, aims to enhance the field of glycobiology by providing a platform for trainees and early-stage researchers. This event will feature presentations from experts in various areas related to glycobiology, including aging, inflammation, and cancer. Participants can engage in networking opportunities and collaborative discussions, both in-person and online, to foster innovation and knowledge sharing in glycoscience. The symposium emphasizes inclusivity, particularly for underrepresented groups in research.
Why it matters
Potential benefit: If successful, this symposium could lead to significant advancements in glycobiology that may improve understanding and treatment of various diseases.
How similar studies have gone: Previous symposiums and conferences in related fields have successfully fostered collaboration and innovation, indicating a positive precedent for this event.
Where this research is happening
-
Versiti Wisconsin, INC.
Milwaukee, United States Active
Researchers
- Principal investigator: Hoffmeister, Karin Maria — Versiti Wisconsin, INC.
- Study coordinator: Hoffmeister, Karin Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.